Tomotherapy as an adjuvant treatment for gastroesophageal junction and stomach cancer may reduce bowel and bone marrow toxicity compared to intensity-modulated radiotherapy and volumetric-modulated arc therapy

Oncotarget. 2017 Jun 13;8(24):39727-39735. doi: 10.18632/oncotarget.14459.

Abstract

Purpose: To compare dosimetric parameters of intensity-modulated radiotherapy (IMRT), volumetric-modulated arc therapy (VMAT) and tomotherapy (TOMO) in the adjuvant treatment of gastroesophageal junction (GEJ)/stomach cancer. The planning goal was to maintain high target coverage while keeping the dose to the bowel and bone marrow (BM) as low as possible.

Materials and methods: After curative surgery, 16 patients with GEJ/stomach cancer were re-planned by coplanar IMRT (five fixed beam), VMAT (double-arc), and TOMO. The dose to the planning target volume (PTV) was 45 Gy in 25 fractions. The target parameters, including the homogeneity index (HI) and conformity index (CI), and doses to the organs at risk (OARs) were analyzed.

Results: Dosimetric parameters for PTV and OARs were comparable among the three techniques. However, TOMO provided improved conformity (CI = 0.92±0.03) and homogeneity (HI = 1.07±0.02) than IMRT (CI = 0.87±0.03; HI = 1.09±0.02; p < 0.05) and VMAT (CI = 0.86±0.03; HI = 1.09±0.02; p < 0.01). TOMO also improved dose sparing of the bowel (percentage of the volume receiving a dose of ≥ 30 Gy [V30] = 23.24±9.85) and BM (V30 = 71.66±6.15) compared with IMRT (bowel V30 = 30.02±11.74; BM V30 = 83.74±8.42; p < 0.01) and VMAT (bowel V30 = 31.88±11.59; BM V30 = 79.51±9.07; p < 0.01).

Conclusions: TOMO is a good option for adjuvant treatment of GEJ/stomach cancer in patients undergoing radical surgery due to its superior bowel and BM dose sparing, dose conformity and dose homogeneity; however, future studies are required to validate its clinical efficacy.

Keywords: gastric cancer; gastroesophageal junction cancer; helical tomotherapy; intensity-modulated radiotherapy; volumetric-modulated arc therapy.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Aged
  • Bone Marrow Diseases / etiology
  • Bone Marrow Diseases / prevention & control*
  • Clinical Trials, Phase II as Topic
  • Esophageal Neoplasms / pathology
  • Esophageal Neoplasms / radiotherapy*
  • Esophagogastric Junction / pathology
  • Esophagogastric Junction / radiation effects*
  • Female
  • Follow-Up Studies
  • Humans
  • Inflammatory Bowel Diseases / etiology
  • Inflammatory Bowel Diseases / prevention & control*
  • Male
  • Middle Aged
  • Organs at Risk / radiation effects
  • Prognosis
  • Prospective Studies
  • Radiotherapy Planning, Computer-Assisted / methods
  • Radiotherapy, Adjuvant / adverse effects*
  • Radiotherapy, Intensity-Modulated / methods*
  • Stomach Neoplasms / pathology
  • Stomach Neoplasms / radiotherapy*